Pacific Biosciences of California, Inc.

NASDAQ:PACB

1.93 (USD) • At close September 18, 2024
Bedrijfsnaam Pacific Biosciences of California, Inc.
Symbool PACB
Munteenheid USD
Prijs 1.93
Beurswaarde 525,980,970
Dividendpercentage 0%
52-weken bereik 1.16 - 10.65
Industrie Medical Devices
Sector Healthcare
CEO Mr. Christian O. Henry M.B.A.
Website https://www.pacb.com

An error occurred while fetching data.

Over Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit

Vergelijkbare Aandelen

Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc.

CLDX

41.85 USD

Clover Health Investments, Corp. logo

Clover Health Investments, Corp.

CLOV

3 USD

Prothena Corporation plc logo

Prothena Corporation plc

PRTA

21.48 USD

Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc.

CTKB

5.06 USD

Exscientia plc logo

Exscientia plc

EXAI

5.22 USD

Veracyte, Inc. logo

Veracyte, Inc.

VCYT

33.76 USD

NextGen Healthcare, Inc. logo

NextGen Healthcare, Inc.

NXGN

23.94 USD

P3 Health Partners Inc. logo

P3 Health Partners Inc.

PIII

0.46 USD

CareDx, Inc logo

CareDx, Inc

CDNA

29.26 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)